PARIS–(BUSINESS WIRE)–Keen Eye, ein französisches Technologieunternehmen, das auf Bildanalysen für die Life-Science-Branche spezialisiert ist, gab heute eine strategische Partnerschaft mit Iris Pharma bekannt, einem weltweit führenden Auftragsforschu…
Month: October 2018
Keen Eye et Iris Pharma s’associent pour intégrer l’intelligence artificielle aux études ophtalmologiques
PARIS–(BUSINESS WIRE)–Keen Eye, entreprise française spécialisée en analyse d’images biomédicales pour le secteur des sciences de la vie, a annoncé aujourd’hui avoir conclu un accord de partenariat stratégique avec Iris Pharma, société de recherche s…
VIDEO: Study shows Omidria helps manage pupil in IFIS cataract surgery cases
NEW YORK — From OSN New York 2018, Steven M. Silverstein, MD, discusses a study showing that Omidria (phenylephrine 1% and ketorolac 0.3% intraocular solution, Omeros) helps manage pupil prolapse, flaccidity and constriction in intraoperative floppy ir…
Children in Milwaukee Receive Free Comprehensive Eye Exams and Prescription Glasses as Part of a School Health Event
MILWAUKEE–(BUSINESS WIRE)–Milwaukee-area children received free eye screenings and prescription glasses as part of a school eye health event.
Brolucizumab meets secondary endpoints for fluid resolution in wet AMD
A new data analysis of prespecified secondary endpoints of the phase 3 HAWK and HARRIER trials showed that retinal fluid was detected less often in patients treated with brolucizumab 6 mg compared with patients treated with aflibercept over four visits…
MedAware Uses AI to Detect Potential Medication Errors: Interview with Dr. Gidi Stein, CEO
Medical errors are the third-leading cause of death in the US and they are probably the most common and preventable. MedAware, an Israeli company, is using the power of artificial intelligence to detect potential errors before they happen. The company was started by Dr. Gidi Stein, MD, PhD, who had spent several years in the […]
MAGNETOM Sola MRI from Siemens with BioMatrix Technology Cleared by FDA
The FDA has cleared the MAGNETOM Sola 1.5 Tesla MRI machine from Siemens Healthineers, a device that features the company’s BioMatrix patient-centric technology, previously only available on 3 Tesla scanners. BioMatrix accounts for different patients sizes and body types, helping clinicians to prepare and perform scans so that rescans don’t have to be performed as […]
Body Vision Releases LungVision for Early-Stage Lung Cancer Diagnostics
Body Vision Medical out of Ramat Ha Sharon, Israel is releasing its LungVision platform for planning, navigating to, and targeting small pulmonary nodules within the peripheral regions of the lungs. The product integrates into bronchoscopy suites and provides a step-by-step process that the company claims doesn’t require a large learning curve. Using augmented reality tools, […]
Study: Mastectomy does not completely eliminate need for future breast imaging
The proportion of breast cancer patients who are eligible for breast conservation therapy, yet opt for mastectomy, is increasing, for reasons that include the desire to eliminate future screening and/or biopsy of the remaining breast tissue.
Ohio State Studying Medical Aspects of Video Games in New Esports Program
At Ohio State University there’s a new program to study various aspects of esports (competitive playing of video games), including medically related issues such as fatigue, long-term problems for players, and how the brain and muscles work together to achieve incredible feats of coordination. The Sports Medicine Movement Analysis and Performance Program at Ohio State […]
European Medicines Agency accepts Rhokiinsa drug application
The European Medicines Agency will begin a marketing authorization application review for Rhokiinsa after accepting the drug application from Aerie Pharmaceuticals, the company announced in a press release.Rhokiinsa (netarsudil ophthalmic solution 0.02…
A Visual Field Defect in a Patient With History of Seizures
A 64-year-old woman comes to you after 2 weeks of symptoms. Between visual testing and MRI, can you offer her a diagnosis? Medscape Ophthalmology
VIDEO: Specialist reviews current options for medical treatment of glaucoma
VIENNA — In 2002, Tony Realini calculated that there are 56,000 ways to treat glaucoma, and now there are many more. At the European Society of Cataract and Refractive Surgeons meeting, Frances Meier-Gibbons, MD, reviews current options, focusing in pa…
How to maximize face-to-face time with patients
The average time of a consultation in primary care rose from 15.56 minutes in 1993 to 21.07 minutes in 2012, research recently published in BMJ found.Though the amount time a primary care physician spends with a patient has improved, less than a half h…
What Could the Midterm Elections Mean for Physicians?
The November 6 midterms could support the Trump administration’s healthcare policy or further the government’s gridlock. Experts weigh in on the election’s potential effects. Medscape Business of Medicine
STAAR Surgical Announces Strategic Alliance Agreement with Dr. Tobias Neuhann in Germany, A Model for Collaboration with Single Site Ophthalmology Clinics
MONROVIA, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced a multi-year Strategic Alliance Agreement with Dr…
STAAR Surgical Announces Strategic Alliance Agreement with Dr. Tobias Neuhann in Germany, A Model for Collaboration with Single Site Ophthalmology Clinics
MONROVIA, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced a multi-year Strategic Alliance Agreement with Dr…
Keen Eye and Iris Pharma Team up to Bring Artificial Intelligence in Ophthalmology Studies
PARIS–(BUSINESS WIRE)–#IrisPharma–Keen Eye and Iris Pharma team up to bring AI in the preclinical ophthalmic drug development to make assays faster, more reliable and more efficient.
Keen Eye and Iris Pharma Team up to Bring Artificial Intelligence in Ophthalmology Studies
PARIS–(BUSINESS WIRE)–#IrisPharma–Keen Eye and Iris Pharma team up to bring AI in the preclinical ophthalmic drug development to make assays faster, more reliable and more efficient.
Aerie Pharmaceuticals, Inc. Announces Drug Application for Regulatory Approval Accepted for Review in Europe
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…